Taikang Asset Management (HK)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,979
Closed -$4.72M 91
2025
Q4
$4.72M Hold
6,979
0.47% 56
2025
Q3
$4.46M Sell
6,979
-3,146
-31% -$1.91M 0.5% 53
2025
Q2
$5.43M Hold
10,125
0.7% 52
2025
Q1
$4.25M Hold
10,125
0.58% 57
2024
Q4
$4.19M Sell
10,125
-7,579
-43% -$3.32M 0.62% 50
2024
Q3
$8.94M Buy
17,704
+8,852
+100% +$4.3M 0.94% 34
2024
Q2
$4.31M Hold
8,852
0.67% 34
2024
Q1
$4.78M Hold
8,852
1.01% 28
2023
Q4
$4.91M Hold
8,852
0.93% 24
2023
Q3
$30.3M Hold
8,852
0.88% 28
2023
Q2
$34.8M Sell
8,852
-8,852
-50% -$4.24M 1.04% 25
2023
Q1
$69.5M Buy
17,704
+28
+0.2% +$13.4K 1.6% 17
2022
Q4
$56.3M Sell
17,676
-1,736
-9% -$674K 1.52% 26
2022
Q3
$49.6M Buy
19,412
+2,346
+14% +$862K 1.3% 30
2022
Q2
$47M Sell
17,066
-126
-0.7% -$51.4K 1.16% 37
2022
Q1
$9.4M Buy
17,192
+8,533
+99% +$4.49M 1.6% 19
2021
Q4
$5.7M Hold
8,659
1.14% 19
2021
Q3
$5.38M Hold
8,659
1.09% 16
2021
Q2
$5.47M Hold
8,659
0.84% 20
2021
Q1
$4.24M Hold
8,659
0.8% 27
2020
Q4
$4.33M Buy
8,659
+788
+10% +$353K 0.64% 25
2020
Q3
$3.09M Buy
7,871
+126
+2% +$46.6K 0.48% 39
2020
Q2
$2.56M Hold
7,745
0.46% 46
2020
Q1
$1.88M Buy
7,745
+1,608
+26% +$420K 0.42% 52
2019
Q4
$1.6M Hold
6,137
0.4% 54
2019
Q3
$1.67M Hold
6,137
0.18% 53
2019
Q2
$1.69M Hold
6,137
0.19% 40
2019
Q1
$1.37M Buy
+6,137
New +$1.27M 0.19% 52

Other funds holding IDXX

Taikang Asset Management (HK)'s IDXX Position: Q1 2026 in Review

Taikang Asset Management (HK) sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 6,979 shares — an estimated $4.72M sold.

Taikang Asset Management (HK) first reported a position in IDXX in Q1 2019 and held it in 28 quarters. The position peaked at $69.5M in Q1 2023. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Taikang Asset Management (HK) reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Taikang Asset Management (HK) sold 6,979 Idexx Laboratories shares in Q1 2026, an estimated $4.72M.
  • Taikang Asset Management (HK) first reported a position in Idexx Laboratories in Q1 2019 and held it in 28 quarters.
  • Taikang Asset Management (HK)'s Idexx Laboratories position peaked at $69.5M in Q1 2023.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Taikang Asset Management (HK)'s 13F filing for Q1 2026, filed 14 May 2026.